Breaking News

Ajinomoto Completes Althea Acquisition

April 5, 2013

Will operate under the name Ajinomoto Althea

Ajinomoto Co., Inc. has completed its acquisition of Althea Technologies, a provider of biopharmaceutical development and manufacturing services, for approximately $175 million. Althea will become a fully consolidated subsidiary of Ajinomoto Co. operating under the company name Ajinomoto Althea, Inc.
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.